Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
The management of orphan drugs in taiwan
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Poster
- By: HSIEH, Yow-Wen (China Medical University Hospital, Pharmacy)
- Co-author(s): Yow-Wen Hsieh
Yih-Dih Cheng: Pharmacy, China Medical University Hospital, Taichung, Taiwan, Province of China
BackgroundThe rare disease patients are usually the disadvantaged minority in the society. In order to provide them with timely and effective treatment, the Taiwan MoHW legislated the regulation called “Rare Disease Control and Orphan Drug Act” in 2000. The Act is used to well manage the Orphan drugs used in Taiwan.
MethodsIn order to let all.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019